Table 1 Summary of clinical and demographic characteristics of the study population
Characteristic | All patients | Second-stage PED/coils | Single-stage PED/coils | P value |
|---|---|---|---|---|
Aneurysms treated, n | 22 | 10 | 12 | |
Age, years, mean (SD) | 62.6 (10.3) | 59.1 (9.4) | 65.6 (10.2) | 0.16 |
Female sex, n | 18 (81.8%) | 7 (70%) | 11 (91.7%) | 0.29 |
Dual antiplatelet therapy | ||||
ASA + Clopidogrel, n | 19 (86.4%) | 10 (100%) | 9 (75.0%) | 0.2 |
ASA + Cilostazol, n | 1 (4.5%) | 0 (0%) | 1 (8.3%) | 1.0 |
ASA + Prasugrel, n | 2 (9.1%) | 0 (0%) | 2 (16.7) | 0.48 |
Aneurysm size, mm, mean (SD) | 18.4 (6.7) | 15.4 (4.2) | 20.9 (7.3) | 0.05 |
Neck size, mm, mean (SD) | 7.1 (3.0) | 6.0 (1.9) | 8.2 (3.4) | 0.10 |
Symptomatic aneurysm, n | 8 (36.4%) | 1 (10%) | 7 (58.3%) | 0.03 |
Follow-up, months, mean (SD) | 29.6 (15.9) | 24.8 (14.1) | 33.7 (16.2) | 0.21 |